These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 29309600)

  • 1. Effect of cholinergic treatment depends on cholinergic integrity in early Alzheimer's disease.
    Richter N; Beckers N; Onur OA; Dietlein M; Tittgemeyer M; Kracht L; Neumaier B; Fink GR; Kukolja J
    Brain; 2018 Mar; 141(3):903-915. PubMed ID: 29309600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatial distributions of cholinergic impairment and neuronal hypometabolism differ in MCI due to AD.
    Richter N; Nellessen N; Dronse J; Dillen K; Jacobs HIL; Langen KJ; Dietlein M; Kracht L; Neumaier B; Fink GR; Kukolja J; Onur OA
    Neuroimage Clin; 2019; 24():101978. PubMed ID: 31422337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease.
    Kaasinen V; Någren K; Järvenpää T; Roivainen A; Yu M; Oikonen V; Kurki T; Rinne JO
    J Clin Psychopharmacol; 2002 Dec; 22(6):615-20. PubMed ID: 12454562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White matter lesions and the cholinergic deficit in aging and mild cognitive impairment.
    Richter N; Michel A; Onur OA; Kracht L; Dietlein M; Tittgemeyer M; Neumaier B; Fink GR; Kukolja J
    Neurobiol Aging; 2017 May; 53():27-35. PubMed ID: 28208063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The integrity of the cholinergic system determines memory performance in healthy elderly.
    Richter N; Allendorf I; Onur OA; Kracht L; Dietlein M; Tittgemeyer M; Neumaier B; Fink GR; Kukolja J
    Neuroimage; 2014 Oct; 100():481-8. PubMed ID: 24952230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age and Anterior Basal Forebrain Volume Predict the Cholinergic Deficit in Patients with Mild Cognitive Impairment due to Alzheimer's Disease.
    Richter N; David LS; Grothe MJ; Teipel S; Dietlein M; Tittgemeyer M; Neumaier B; Fink GR; Onur OA; Kukolja J
    J Alzheimers Dis; 2022; 86(1):425-440. PubMed ID: 35068451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease.
    Rombouts SA; Barkhof F; Van Meel CS; Scheltens P
    J Neurol Neurosurg Psychiatry; 2002 Dec; 73(6):665-71. PubMed ID: 12438467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation--a pharmacological fMRI study.
    Goekoop R; Scheltens P; Barkhof F; Rombouts SA
    Brain; 2006 Jan; 129(Pt 1):141-57. PubMed ID: 16251213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Entorhinal Tau Predicts Hippocampal Activation and Memory Deficits in Alzheimer's Disease.
    Richter N; Bischof GN; Dronse J; Nellessen N; Neumaier B; Langen KJ; Drzezga A; Fink GR; van Eimeren T; Kukolja J; Onur OA
    J Alzheimers Dis; 2020; 78(4):1601-1614. PubMed ID: 33164934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and molecular cholinergic imaging markers of cognitive decline in Parkinson's disease.
    Schumacher J; Kanel P; Dyrba M; Storch A; Bohnen NI; Teipel S; Grothe MJ
    Brain; 2023 Dec; 146(12):4964-4973. PubMed ID: 37403733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinergic activity correlates with reserve proxies in Alzheimer's disease.
    Garibotto V; Tettamanti M; Marcone A; Florea I; Panzacchi A; Moresco R; Virta JR; Rinne J; Cappa SF; Perani D
    Neurobiol Aging; 2013 Nov; 34(11):2694.e13-8. PubMed ID: 23820589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer's dementia.
    Sabri O; Meyer PM; Gräf S; Hesse S; Wilke S; Becker GA; Rullmann M; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Tiepolt S; Fischer S; Deuther-Conrad W; Hegerl U; Barthel H; Schönknecht P; Brust P
    Brain; 2018 Jun; 141(6):1840-1854. PubMed ID: 29672680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dementia with Lewy bodies can be well-differentiated from Alzheimer's disease by measurement of brain acetylcholinesterase activity-a [11C]MP4A PET study.
    Shimada H; Hirano S; Sinotoh H; Ota T; Tanaka N; Sato K; Yamada M; Fukushi K; Irie T; Zhang MR; Higuchi M; Kuwabara S; Suhara T
    Int J Geriatr Psychiatry; 2015 Nov; 30(11):1105-13. PubMed ID: 26280153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain acetylcholinesterase activity in mild cognitive impairment and early Alzheimer's disease.
    Rinne JO; Kaasinen V; Järvenpää T; Någren K; Roivainen A; Yu M; Oikonen V; Kurki T
    J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):113-5. PubMed ID: 12486280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cholinergic stimulation in early Alzheimer's disease - functional imaging during a recognition memory task.
    Miettinen PS; Pihlajamäki M; Jauhiainen AM; Tarkka IM; Gröhn H; Niskanen E; Hänninen T; Vanninen R; Soininen H
    Curr Alzheimer Res; 2011 Nov; 8(7):753-64. PubMed ID: 21592058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotection of Cholinergic Neurons with a Tau Aggregation Inhibitor and Rivastigmine in an Alzheimer's-like Tauopathy Mouse Model.
    Zadrozny M; Drapich P; Gasiorowska-Bien A; Niewiadomski W; Harrington CR; Wischik CM; Riedel G; Niewiadomska G
    Cells; 2024 Apr; 13(7):. PubMed ID: 38607082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [11C]-MP4A PET cholinergic measurements in amnestic mild cognitive impairment, probable Alzheimer's disease, and dementia with Lewy bodies: a Bayesian method and voxel-based analysis.
    Marcone A; Garibotto V; Moresco RM; Florea I; Panzacchi A; Carpinelli A; Virta JR; Tettamanti M; Borroni B; Padovani A; Bertoldo A; Herholz K; Rinne JO; Cappa SF; Perani D
    J Alzheimers Dis; 2012; 31(2):387-99. PubMed ID: 22596267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced cortical cholinergic innervation measured using [
    Xia Y; Eeles E; Fripp J; Pinsker D; Thomas P; Latter M; Doré V; Fazlollahi A; Bourgeat P; Villemagne VL; Coulson EJ; Rose S
    Neuroimage Clin; 2022; 34():102992. PubMed ID: 35344804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular imaging of serotonin degeneration in mild cognitive impairment.
    Smith GS; Barrett FS; Joo JH; Nassery N; Savonenko A; Sodums DJ; Marano CM; Munro CA; Brandt J; Kraut MA; Zhou Y; Wong DF; Workman CI
    Neurobiol Dis; 2017 Sep; 105():33-41. PubMed ID: 28511918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of donepezil on cortical metabolic response to activation during (18)FDG-PET in Alzheimer's disease: a double-blind cross-over trial.
    Teipel SJ; Drzezga A; Bartenstein P; Möller HJ; Schwaiger M; Hampel H
    Psychopharmacology (Berl); 2006 Jul; 187(1):86-94. PubMed ID: 16767418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.